What is AI in Clinical Trials?

AI in clinical trials refers to the integration of artificial intelligence technologies, such as machine learning, natural language processing, and deep learning, to enhance the efficiency, effectiveness, and accuracy of clinical research. It involves automating data collection, improving patient selection, optimizing trial design, and facilitating faster and more reliable decision-making processes.

How big is the AI In Clinical Trial Market?

The global AI In Clinical Trial Market size was estimated at USD 1.8 Billion in 2023 and is expected to reach USD 22.3 Billion in 2033.

What is the AI In Clinical Trial Market growth?

The global AI In Clinical Trial Market is expected to grow at a compound annual growth rate of 28.6%. From 2024 To 2033

Who are the key companies/players in the AI In Clinical Trial Market?

Some of the key players in the AI In Clinical Trial Markets are Phesi, Intelligencia, DEEP LENS AI, Halo Health Systems, Pharmaseal, Koneksa Health, BioSymetrics, Google-Verify, IBM Watson, Symphony AI, BioAge Labs, Inc, Ardigen.

How is AI transforming Clinical Trials?

AI transforms clinical trials by streamlining operations, from patient recruitment to data analysis. It enables the identification of suitable candidates through electronic health records, improves protocol design by predicting outcomes and adverse events, and accelerates data processing for quicker trial conclusions, thereby reducing time and costs significantly.

What are the key benefits of using AI in Clinical Trials?

Key benefits include increased efficiency through automation, enhanced patient matching and recruitment, improved data accuracy, faster identification of drug efficacy and safety signals, and overall reduction in trial duration and cost. AI can also unlock insights from vast datasets, leading to more informed decision-making.

What challenges are associated with implementing AI in Clinical Trials?

Challenges include data privacy and security concerns, the need for substantial data sets to train AI models, regulatory and ethical considerations, the requirement for clear interpretability of AI decisions, and the potential for increased initial setup costs and complexity.

Global AI in Clinical Trial Market By Offerings (Software, Services), By Technology (Machine Learning, Deep learning, Supervised), By Application (Cardiovascular, Metabolic, Oncology, Infectious diseases), By End-Use (Pharmaceutical, Biotechnology, CROs), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Published date: March 2024
Report ID: 116297
Number of Pages: 352
Format:

Table of Contents
- 1.Executive Summary
  - 1.1.Definition
  - 1.2.Market Snapshot
  - 1.3.Market Overview
  - 1.4.Segment Overview
  - 1.5.Regional Overview
  - 1.6.Competitive Landscape
  - 1.7. Taxonomy
- 2.Global AI in Clinical Trial Market Overview
  - 2.1.Global Market Insights and Industry Overview
  - 2.2.Market Dynamics
    2.2.1.Drivers
    2.2.2.Restraints
    2.2.3.Opportunities
    2.2.4.Key AI in Clinical Trial Market Trends
  - 2.3.Regulatory Framework
  - 2.4.Opportunity Map Analysis
  - 2.5.Opportunity Orbits
  - 2.6.PESTLE Analysis
  - 2.7.PORTER’S Five Force Analysis
  - 2.8.Drivers & Restraints Impact Analysis
  - 2.9.Value Chain Analysis
    2.9.1.List of Raw Materials Suppliers
    2.9.2.List of AI in Clinical Trial Manufacturers
    2.9.3.List of Dealer/Distributors
  - 2.10.Regional Market Share and BPS Analysis
  - 2.11.Impact of Macro-Economic Factors/Geopolitical Factors
- 3.Global AI in Clinical Trial Market Analysis and Forecast, By Segment, 2024-2033
  - 3.1.Key Findings
  - 3.2.Global AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Offerings, 2024-2033
  - 3.3.Global AI in Clinical Trial Market Attractiveness Analysis, By Offerings
    3.3.1.Software
    3.3.1.1.Insights
    3.3.1.2.Key Takeaways
    3.3.2.Services
    3.3.2.1.Insights
    3.3.2.2.Key Takeaways
  - 3.4.Global AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2024-2033
  - 3.5.Global AI in Clinical Trial Market Attractiveness Analysis, By Technology
    3.5.1.Machine learning
    3.5.1.1.Insights
    3.5.1.2.Key Takeaways
    3.5.2.Deep learning
    3.5.2.1.Insights
    3.5.2.2.Key Takeaways
    3.5.3.Supervised
    3.5.3.1.Insights
    3.5.3.2.Key Takeaways
  - 3.6.Global AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 3.7.Global AI in Clinical Trial Market Attractiveness Analysis, By Application
    3.7.1.Cardiovascular
    3.7.1.1.Insights
    3.7.1.2.Key Takeaways
    3.7.2.Metabolic
    3.7.2.1.Insights
    3.7.2.2.Key Takeaways
    3.7.3.Oncology
    3.7.3.1.Insights
    3.7.3.2.Key Takeaways
    3.7.4.Infectious Diseases
    3.7.4.1.Insights
    3.7.4.2.Key Takeaways
  - 3.8.Global AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 3.9.Global AI in Clinical Trial Market Attractiveness Analysis, By End-User
    3.9.1.Pharmaceutical companies
    3.9.1.1.Insights
    3.9.1.2.Key Takeaways
    3.9.2.Biotechnology companies
    3.9.2.1.Insights
    3.9.2.2.Key Takeaways
    3.9.3.Contract Research Organizations
    3.9.3.1.Insights
    3.9.3.2.Key Takeaways
- 4.Global AI in Clinical Trial Market Analysis and Forecast, By Region, 2024-2033
  - 4.1.Key Findings
  - 4.2.Global AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2024-2033
    4.2.1.North America
    4.2.1.1.Regional Insights
    4.2.2.Europe
    4.2.2.1.Regional Insights
    4.2.3.Asia Pacific
    4.2.3.1.Regional Insights
    4.2.4.Latin America
    4.2.4.1.Regional Insights
    4.2.5.Middle East & Africa
    4.2.5.1.Regional Insights
  - 4.3.Global AI in Clinical Trial Market Attractiveness Analysis, By Region
- 5.North America AI in Clinical Trial Market Analysis and Forecast, 2024-2033
  - 5.1.Key Findings
  - 5.2.North America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Offerings, 2024-2033
  - 5.3.North America AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - 5.4.North America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2024-2033
  - 5.5.North America AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - 5.6.North America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 5.7.North America AI in Clinical Trial Market Attractiveness Analysis, By Application
  - 5.8.North America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 5.9.North America AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - 5.10.North America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 5.11.North America AI in Clinical Trial Market Attractiveness Analysis, By Country
    5.11.1.The US
    5.11.2.Canada
- 6.Europe AI in Clinical Trial Market Analysis and Forecast, 2024-2033
  - 6.1.Key Findings
  - 6.2.Europe AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Offerings, 2024-2033
  - 6.3.Europe AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - 6.4.Europe AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2024-2033
  - 6.5.Europe AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - 6.6.Europe AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 6.7.Europe AI in Clinical Trial Market Attractiveness Analysis, By Application
  - 6.8.Europe AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 6.9.Europe AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - 6.10.Europe AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 6.11.Europe AI in Clinical Trial Market Attractiveness Analysis, By Country
    6.11.1.Germany
    6.11.2.The UK
    6.11.3.France
    6.11.4.Spain
    6.11.5.Italy
    6.11.6.Russia
    6.11.7.Netherlands
    6.11.8.Rest of Europe
- 7.Asia Pacific AI in Clinical Trial Market Analysis and Forecast, 2024-2033
  - 7.1.Key Findings
  - 7.2.Asia Pacific AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Offerings, 2024-2033
  - 7.3.Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - 7.4.Asia Pacific AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2024-2033
  - 7.5.Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - 7.6.Asia Pacific AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 7.7.Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By Application
  - 7.8.Asia Pacific AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 7.9.Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - 7.10.Asia Pacific AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 7.11.Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By Country
    7.11.1.China
    7.11.2.Japan
    7.11.3.South Korea
    7.11.4.India
    7.11.5.New Zealand
    7.11.6.Singapore
    7.11.7.Thailand
    7.11.8.Vietnam
    7.11.9.Rest of Asia Pacific
- 8.Latin America AI in Clinical Trial Market Analysis and Forecast, 2024-2033
  - 8.1.Key Findings
  - 8.2.Latin America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Offerings, 2024-2033
  - 8.3.Latin America AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - 8.4.Latin America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2024-2033
  - 8.5.Latin America AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - 8.6.Latin America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 8.7.Latin America AI in Clinical Trial Market Attractiveness Analysis, By Application
  - 8.8.Latin America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 8.9.Latin America AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - 8.10.Latin America AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 8.11.Latin America AI in Clinical Trial Market Attractiveness Analysis, By Country
    8.11.1.Brazil
    8.11.2.Mexico
    8.11.3.Rest of Latin America
- 9.Middle East & Africa AI in Clinical Trial Market Analysis and Forecast, 2024-2033
  - 9.1.Key Findings
  - 9.2.Middle East & Africa AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Offerings, 2024-2033
  - 9.3.Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - 9.4.Middle East & Africa AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2024-2033
  - 9.5.Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - 9.6.Middle East & Africa AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 9.7.Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By Application
  - 9.8.Middle East & Africa AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 9.9.Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - 9.10.Middle East & Africa AI in Clinical Trial Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 9.11.Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By Country
    9.11.1.South Africa
    9.11.2.Saudi Arabia
    9.11.3.UAE
    9.11.4.Rest of Middle East & Africa
- 10.Competitive Landscape & Company Profiles
  - 10.1.Market Competition Scenario Analysis, By Company
    10.1.1.Key Takeaways
  - 10.2.Overview of Major Market Players
  - 10.3.Competitor Landscape
  - 10.4.Strategic Mapping
  - 10.5.Company Life Cycle Analysis
  - 10.6.Company Market Share Analysis
  - 10.7.Company Profiles
  - 10.7.1.Phesi
    10.7.1.1.Company Details
    10.7.1.2.Business Overview
    10.7.1.3.Product Portfolio
    10.7.1.4.Financial Insights
    10.7.1.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6.SWOT Analysis
    10.7.1.7.Geographic Footprint
  - 10.7.2.Intelligencia
    10.7.2.1.Company Details
    10.7.2.2.Business Overview
    10.7.2.3.Product Portfolio
    10.7.2.4.Financial Insights
    10.7.2.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6.SWOT Analysis
    10.7.2.7.Geographic Footprint
  - 10.7.3.DEEP LENS AI
    10.7.3.1.Company Details
    10.7.3.2.Business Overview
    10.7.3.3.Product Portfolio
    10.7.3.4.Financial Insights
    10.7.3.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6.SWOT Analysis
    10.7.3.7.Geographic Footprint
  - 10.7.4.Halo Health Systems
    10.7.4.1.Company Details
    10.7.4.2.Business Overview
    10.7.4.3.Product Portfolio
    10.7.4.4.Financial Insights
    10.7.4.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6.SWOT Analysis
    10.7.4.7.Geographic Footprint
  - 10.7.5.Pharmaseal
    10.7.5.1.Company Details
    10.7.5.2.Business Overview
    10.7.5.3.Product Portfolio
    10.7.5.4.Financial Insights
    10.7.5.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6.SWOT Analysis
    10.7.5.7.Geographic Footprint
  - 10.7.6.Koneksa Health
    10.7.6.1.Company Details
    10.7.6.2.Business Overview
    10.7.6.3.Product Portfolio
    10.7.6.4.Financial Insights
    10.7.6.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6.SWOT Analysis
    10.7.6.7.Geographic Footprint
  - 10.7.7.BioSymetrics
    10.7.7.1.Company Details
    10.7.7.2.Business Overview
    10.7.7.3.Product Portfolio
    10.7.7.4.Financial Insights
    10.7.7.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6.SWOT Analysis
    10.7.7.7.Geographic Footprint
  - 10.7.8.Google- Verify
    10.7.8.1.Company Details
    10.7.8.2.Business Overview
    10.7.8.3.Product Portfolio
    10.7.8.4.Financial Insights
    10.7.8.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6.SWOT Analysis
    10.7.8.7.Geographic Footprint
  - 10.7.9.IBM Watson
    10.7.9.1.Company Details
    10.7.9.2.Business Overview
    10.7.9.3.Product Portfolio
    10.7.9.4.Financial Insights
    10.7.9.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6.SWOT Analysis
    10.7.9.7.Geographic Footprint
  - 10.7.10.Symphony AI
    10.7.10.1.Company Details
    10.7.10.2.Business Overview
    10.7.10.3.Product Portfolio
    10.7.10.4.Financial Insights
    10.7.10.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6.SWOT Analysis
    10.7.10.7.Geographic Footprint
  - 10.7.11.BioAge Labs., Inc
    10.7.11.1.Company Details
    10.7.11.2.Business Overview
    10.7.11.3.Product Portfolio
    10.7.11.4.Financial Insights
    10.7.11.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.11.6.SWOT Analysis
    10.7.11.7.Geographic Footprint
  - 10.7.12.Ardigen
    10.7.12.1.Company Details
    10.7.12.2.Business Overview
    10.7.12.3.Product Portfolio
    10.7.12.4.Financial Insights
    10.7.12.5.Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.12.6.SWOT Analysis
    10.7.12.7.Geographic Footprint
- 11.Methodology and Data Source
  - 11.1.Methodology/Research Approach
  - 11.2.Market Size Estimation
  - 11.3.Market Breakdown and Data Triangulation
  - 11.4.Data Source
  - 11.5.Secondary Sources
  - 11.6.Primary Sources
  - 11.7.Appendix
  - 11.8.Disclaimer
- List of Tables
  - Table 1. Global AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 2. Global AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 3. Global AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 4. Global AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 5. Global AI in Clinical Trial Market Value (US$ Mn), By Region, 2024-2033
  - Table 6. North America AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 7. North America AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 8. North America AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 9. North America AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 10. North America AI in Clinical Trial Market Value (US$ Mn), By Country, 2024-2033
  - Table 11. The US AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 12. The US AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 13. The US AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 14. The US AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 15. Canada AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 16. Canada AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 17. Canada AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 18. Canada AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 19. Europe AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 20. Europe AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 21. Europe AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 22. Europe AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 23. Europe AI in Clinical Trial Market Value (US$ Mn), By Country, 2024-2033
  - Table 24. Germany AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 25. Germany AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 26. Germany AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 27. Germany AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 28. The UK AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 29. The UK AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 30. The UK AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 31. The UK AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 32. France AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 33. France AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 34. France AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 35. France AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 36. Spain AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 37. Spain AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 38. Spain AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 39. Spain AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 40. Italy AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 41. Italy AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 42. Italy AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 43. Italy AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 44. Russia AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 45. Russia AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 46. Russia AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 47. Russia AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 48. Netherlands AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 49. Netherlands AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 50. Netherlands AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 51. Netherlands AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 52. Rest of Europe AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 53. Rest of Europe AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 54. Rest of Europe AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 55. Rest of Europe AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 56. Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 57. Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 58. Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 59. Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 60. Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By Country, 2024-2033
  - Table 61. China AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 62. China AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 63. China AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 64. China AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 65. India AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 66. Global AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 67. Global AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 68. Global AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 69. Japan AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 70. Japan AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 71. Japan AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 72. Japan AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 73. South Korea AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 74. South Korea AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 75. South Korea AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 76. South Korea AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 77. New Zealand AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 78. New Zealand AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 79. New Zealand AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 80. New Zealand AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 81. Singapore AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 82. Singapore AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 83. Singapore AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 84. Singapore AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 85. Thailand AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 86. Thailand AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 87. Thailand AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 88. Thailand AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 89. Vietnam AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 90. Vietnam AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 91. Vietnam AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 92. Vietnam AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 93. Rest of Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 94. Rest of Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 95. Rest of Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 96. Rest of Asia Pacific AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 97. Latin America AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 98. Latin America AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 99. Latin America AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 100. Latin America AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 101. Latin America AI in Clinical Trial Market Value (US$ Mn), By Country, 2024-2033
  - Table 102. Brazil AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 103. Brazil AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 104. Brazil AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 105. Brazil AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 106. Mexico AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 107. Mexico AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 108. Mexico AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 109. Mexico AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 110. Rest of Latin America AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 111. Rest of Latin America AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 112. Rest of Latin America AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 113. Rest of Latin America AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 114. Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 115. Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 116. Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 117. Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 118. Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By Country, 2024-2033
  - Table 119. South Africa AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 120. South Africa AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 121. South Africa AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 122. South Africa AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 123. Saudi Arabia AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 124. Saudi Arabia AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 125. Saudi Arabia AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 126. Saudi Arabia AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 127. UAE AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 128. UAE AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 129. UAE AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 130. UAE AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
  - Table 131. Rest of Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By Offerings, 2024-2033
  - Table 132. Rest of Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By Technology, 2024-2033
  - Table 133. Rest of Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By Application, 2024-2033
  - Table 134. Rest of Middle East & Africa AI in Clinical Trial Market Value (US$ Mn), By End-User, 2024-2033
- List of Figures
  - Figure 1. Global AI in Clinical Trial Market Snapshot: Market Value (US$ Mn), 2024-2033
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in AI in Clinical Trial Market
  - Figure 5. Global AI in Clinical Trial Market Analysis, By Offerings, 2018, 2023 and 2033
  - Figure 6. Global AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - Figure 7. Global AI in Clinical Trial Market Analysis, By Technology, 2018, 2023 and 2033
  - Figure 8. Global AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - Figure 9. Global AI in Clinical Trial Market Analysis, By Application, 2018, 2023 and 2033
  - Figure 10. Global AI in Clinical Trial Market Attractiveness Analysis, By Application
  - Figure 11. Global AI in Clinical Trial Market Analysis, By End-User, 2018, 2023 and 2033
  - Figure 12. Global AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - Figure 13. North America AI in Clinical Trial Market Analysis, By Offerings, 2018, 2023 and 2033
  - Figure 14. North America AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - Figure 15. North America AI in Clinical Trial Market (US$ Mn), by Software, 2024-2033
  - Figure 16. North America AI in Clinical Trial Market (US$ Mn), by Services, 2024-2033
  - Figure 17. North America AI in Clinical Trial Market Analysis, By Technology, 2018, 2023 and 2033
  - Figure 18. North America AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - Figure 19. North America AI in Clinical Trial Market (US$ Mn), by Machine learning, 2024-2033
  - Figure 20. North America AI in Clinical Trial Market (US$ Mn), by Deep learning, 2024-2033
  - Figure 21. North America AI in Clinical Trial Market (US$ Mn), by Supervised, 2024-2033
  - Figure 22. North America AI in Clinical Trial Market Analysis, By Application, 2018, 2023 and 2033
  - Figure 23. North America AI in Clinical Trial Market Attractiveness Analysis, By Application
  - Figure 24. North America AI in Clinical Trial Market (US$ Mn), by Cardiovascular, 2024-2033
  - Figure 25. North America AI in Clinical Trial Market (US$ Mn), by Metabolic, 2024-2033
  - Figure 26. North America AI in Clinical Trial Market (US$ Mn), by Oncology, 2024-2033
  - Figure 27. North America AI in Clinical Trial Market (US$ Mn), by Infectious Diseases, 2024-2033
  - Figure 28. North America AI in Clinical Trial Market Analysis, By End-User, 2018, 2023 and 2033
  - Figure 29. North America AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - Figure 30. North America AI in Clinical Trial Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 31. North America AI in Clinical Trial Market (US$ Mn), by Biotechnology companies, 2024-2033
  - Figure 32. North America AI in Clinical Trial Market (US$ Mn), by Contract Research Organizations, 2024-2033
  - Figure 33. North America AI in Clinical Trial Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 34. North America AI in Clinical Trial Market Attractiveness Analysis, By Country
  - Figure 35. Europe AI in Clinical Trial Market Analysis, By Offerings, 2018, 2023 and 2033
  - Figure 36. Europe AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - Figure 37. Europe AI in Clinical Trial Market (US$ Mn), by Software, 2024-2033
  - Figure 38. Europe AI in Clinical Trial Market (US$ Mn), by Services, 2024-2033
  - Figure 39. Europe AI in Clinical Trial Market Analysis, By Technology, 2018, 2023 and 2033
  - Figure 40. Europe AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - Figure 41. Europe AI in Clinical Trial Market (US$ Mn), by Machine learning, 2024-2033
  - Figure 42. Europe AI in Clinical Trial Market (US$ Mn), by Deep learning, 2024-2033
  - Figure 43. Europe AI in Clinical Trial Market (US$ Mn), by Supervised, 2024-2033
  - Figure 44. Europe AI in Clinical Trial Market Analysis, By Application, 2018, 2023 and 2033
  - Figure 45. Europe AI in Clinical Trial Market Attractiveness Analysis, By Application
  - Figure 46. Europe AI in Clinical Trial Market (US$ Mn), by Cardiovascular, 2024-2033
  - Figure 47. Europe AI in Clinical Trial Market (US$ Mn), by Metabolic, 2024-2033
  - Figure 48. Europe AI in Clinical Trial Market (US$ Mn), by Oncology, 2024-2033
  - Figure 49. Europe AI in Clinical Trial Market (US$ Mn), by Infectious Diseases, 2024-2033
  - Figure 50. Europe AI in Clinical Trial Market Analysis, By End-User, 2018, 2023 and 2033
  - Figure 51. Europe AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - Figure 52. Europe AI in Clinical Trial Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 53. Europe AI in Clinical Trial Market (US$ Mn), by Biotechnology companies, 2024-2033
  - Figure 54. Europe AI in Clinical Trial Market (US$ Mn), by Contract Research Organizations, 2024-2033
  - Figure 55. Europe AI in Clinical Trial Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 56. Europe AI in Clinical Trial Market Attractiveness Analysis, By Country
  - Figure 57. Asia Pacific AI in Clinical Trial Market Analysis, By Offerings, 2018, 2023 and 2033
  - Figure 58. Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - Figure 59. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Software, 2024-2033
  - Figure 60. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Services, 2024-2033
  - Figure 61. Asia Pacific AI in Clinical Trial Market Analysis, By Technology, 2018, 2023 and 2033
  - Figure 62. Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - Figure 63. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Machine learning, 2024-2033
  - Figure 64. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Deep learning, 2024-2033
  - Figure 65. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Supervised, 2024-2033
  - Figure 66. Asia Pacific AI in Clinical Trial Market Analysis, By Application, 2018, 2023 and 2033
  - Figure 67. Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By Application
  - Figure 68. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Cardiovascular, 2024-2033
  - Figure 69. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Metabolic, 2024-2033
  - Figure 70. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Oncology, 2024-2033
  - Figure 71. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Infectious Diseases, 2024-2033
  - Figure 72. Asia Pacific AI in Clinical Trial Market Analysis, By End-User, 2018, 2023 and 2033
  - Figure 73. Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - Figure 74. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 75. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Biotechnology companies, 2024-2033
  - Figure 76. Asia Pacific AI in Clinical Trial Market (US$ Mn), by Contract Research Organizations, 2024-2033
  - Figure 77. Asia Pacific AI in Clinical Trial Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 78. Asia Pacific AI in Clinical Trial Market Attractiveness Analysis, By Country
  - Figure 79. Latin America AI in Clinical Trial Market Analysis, By Offerings, 2018, 2023 and 2033
  - Figure 80. Latin America AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - Figure 81. Latin America AI in Clinical Trial Market (US$ Mn), by Software, 2024-2033
  - Figure 82. Latin America AI in Clinical Trial Market (US$ Mn), by Services, 2024-2033
  - Figure 83. Latin America AI in Clinical Trial Market Analysis, By Technology, 2018, 2023 and 2033
  - Figure 84. Latin America AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - Figure 85. Latin America AI in Clinical Trial Market (US$ Mn), by Machine learning, 2024-2033
  - Figure 86. Latin America AI in Clinical Trial Market (US$ Mn), by Deep learning, 2024-2033
  - Figure 87. Latin America AI in Clinical Trial Market (US$ Mn), by Supervised, 2024-2033
  - Figure 88. Latin America AI in Clinical Trial Market Analysis, By Application, 2018, 2023 and 2033
  - Figure 89. Latin America AI in Clinical Trial Market Attractiveness Analysis, By Application
  - Figure 90. Latin America AI in Clinical Trial Market (US$ Mn), by Cardiovascular, 2024-2033
  - Figure 91. Latin America AI in Clinical Trial Market (US$ Mn), by Metabolic, 2024-2033
  - Figure 92. Latin America AI in Clinical Trial Market (US$ Mn), by Oncology, 2024-2033
  - Figure 93. Latin America AI in Clinical Trial Market (US$ Mn), by Infectious Diseases, 2024-2033
  - Figure 94. Latin America AI in Clinical Trial Market Analysis, By End-User, 2018, 2023 and 2033
  - Figure 95. Latin America AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - Figure 96. Latin America AI in Clinical Trial Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 97. Latin America AI in Clinical Trial Market (US$ Mn), by Biotechnology companies, 2024-2033
  - Figure 98. Latin America AI in Clinical Trial Market (US$ Mn), by Contract Research Organizations, 2024-2033
  - Figure 99. Latin America AI in Clinical Trial Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 100. Latin America AI in Clinical Trial Market Attractiveness Analysis, By Country
  - Figure 101. Middle East & Africa AI in Clinical Trial Market Analysis, By Offerings, 2018, 2023 and 2033
  - Figure 102. Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By Offerings
  - Figure 103. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Software, 2024-2033
  - Figure 104. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Services, 2024-2033
  - Figure 105. Middle East & Africa AI in Clinical Trial Market Analysis, By Technology, 2018, 2023 and 2033
  - Figure 106. Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By Technology
  - Figure 107. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Machine learning, 2024-2033
  - Figure 108. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Deep learning, 2024-2033
  - Figure 109. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Supervised, 2024-2033
  - Figure 110. Middle East & Africa AI in Clinical Trial Market Analysis, By Application, 2018, 2023 and 2033
  - Figure 111. Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By Application
  - Figure 112. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Cardiovascular, 2024-2033
  - Figure 113. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Metabolic, 2024-2033
  - Figure 114. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Oncology, 2024-2033
  - Figure 115. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Infectious Diseases, 2024-2033
  - Figure 116. Middle East & Africa AI in Clinical Trial Market Analysis, By End-User, 2018, 2023 and 2033
  - Figure 117. Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By End-User
  - Figure 118. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 119. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Biotechnology companies, 2024-2033
  - Figure 120. Middle East & Africa AI in Clinical Trial Market (US$ Mn), by Contract Research Organizations, 2024-2033
  - Figure 121. Middle East & Africa AI in Clinical Trial Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 122. Middle East & Africa AI in Clinical Trial Market Attractiveness Analysis, By Country
- Phesi
- Intelligencia
- DEEP LENS AI
- Halo Health Systems
- Pharmaseal
- Koneksa Health
- BioSymetrics
- Google-Verify
- IBM Watson
- Symphony AI
- BioAge Labs, Inc
- Ardigen
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)